The majority of patients who suffer from migraine experience premonitory symptoms and are able to predict at least 1 attack, according to a new study.
While headache is the most recognized symptom of migraine, migraine attacks often encompass a wide range of symptoms, including premonitory symptoms prior to the episode. The majority of patients who suffer from migraine experience these premonitory symptoms and are able to predict at least 1 attack, according to a new study.
Premonitory symptoms have been characterized as symptoms that precede and alert patients of a migraine between hours and 2 days in advance, including euphoria, fatigue, depression, increased appetite, or food cravings.
“Studying these symptoms is valuable as they are the first patients report during an attack and can indicate which anatomical regions and neurochemical mechanisms are affected at onset,” wrote the researchers of the study. “Another important factor, suggested in several papers, is the administration of the treatment during this phase with the aim of anticipating and preventing the pain onset.”
To read more on migraine symptoms, click here.
The researchers studied 34 patients who experienced between 1 and 8 migraine attacks per month. Patients used a mobile application to reported baseline data, including sex, age, confirmation of migraine diagnosis with or without aura, age at onset, overall qualities of pain, pain frequency, and current preventive treatments.
Researchers followed the patients for 2 months as they used the mobile application to record what they believed to be premonitory symptoms and onset of pain, if it occurred. When a migraine attack ended, participants completed a form on the characteristics of the episode, including the presence of premonitory symptoms not identified prior to the attack.
A total of 229 migraine attacks were recorded, of which 158 (69%) were accompanied by premonitory symptoms. A total of 29 patients experienced premonitory symptoms during at least 1 episode. The mean number of premonitory symptoms recorded was 4.3 per episode, and the mean time of symptom presence was 10 hours and 38 minutes prior to pain onset. Symptoms identified closest to pain onset were nausea and vomiting, apathy, difficulty concentrating, blurred vision, and neck stiffness.
Twenty-three patients were able to predict an attack at least once, implying that patients have a 67.6% likelihood of predicting attacks on occasion, noted the authors. Of those patients, 12 were considered good predictors and were able to predict more than 50% of attacks. Meanwhile, just 4 (11.8%) were always able to predict attacks when accompanied by premonitory symptoms. Eleven patients never predicted an attack.
The authors noted that good predictors of migraine attacks could not be characterized by any specific profile. “An analysis of whether any baseline characteristics increased patients’ likelihood of being able to predict some attack or being a good predictor revealed no statistically significant differences, including sex, age, years form onset headache, and cognitive reserve and associated preventive treatment,” they wrote.
Reference:
Gago-Veiga A, Pagán J, Henares K, et al. To what extent are patients with migraine able to predict attacks? [Published September 27, 2018]. J Pain Res. doi: https://doi.org/10.2147/JPR.S175602.
Incorporating Discussions of Cannabis Use Into Oncology Care Visits
September 15th 2024The legalization of recreational marijuana in Minnesota has created daily conversations about how to incorporate the use of cannabis into treatment plans for patients with cancer, explained Marie Parish, PharmD, BCOP, of Mayo Clinic.
Read More
Update on Migraine Patient Care Challenges During the Pandemic
October 5th 2021Migraines plague some 35 million Americans, the majority of them women in their 30s and 40s, and disabling pain and symptoms are linked to lost productivity at work, school, and home. On this episode of Managed Care Cast, we bring you an excerpt of an interview with a headache specialist about the extra challenges for patients and providers during the pandemic.
Listen
Prior Authorization Requirements for Calcitonin Gene-Related Peptide Antagonists
April 20th 2023This quantitative and qualitative analysis highlights differences in prior authorization requirements for migraine drugs from nearly 50 managed care organizations and summarizes broad types of criteria used.
Read More
How Can Digital Care Programs Aid Those With Chronic Musculoskeletal Pain?
June 9th 2020On this episode of Managed Care Cast, we speak with Jeffrey Krauss, MD, chief medical officer of Hinge Health and Stanford Clinical assistant professor, about the efficacy of a 12-week digital care program aimed to reduce lower back and knee pain in a real-world population.
Listen
Care for Migraine Insufficient in Germany, Online Survey Finds
March 25th 2022An online survey of migraineurs in Germany aimed to evaluate their most pressing unmet needs, with data collected on socioeconomic background, medical care experience, acute medication use, and migraine prophylaxis use and experience.
Read More